new glp 1 medication Novo's Wegovy becomes first GLP-1 drug approved for MASH Swiss Re says GLP-1 drugs

Our finding that tirzepatide increases glucagon secretion in isolated islets not only demonstrates meaningful activity at the GIPR but also provides evidence that tirzepatide can overcome the activity at the GLP-1R on glucagon secretion in human islets

When combined with the attenuation of acute LCAC-induced electrophysiological derangements associated with POCA inhibition of CPT I (Schmidt-Schweda and Holubarsch, 2000)

Another strategy for both siRNAs and ASOs is conjugating them to carrier molecules such as peptides or nanoparticles

PMid:8399039

Obesity diminishes synaptic markers, alters microglial morphology, and impairs cognitive function